nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0663	0.0849	CbGbCtD
Pyrimethamine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.053	0.0679	CbGbCtD
Pyrimethamine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0479	0.0614	CbGbCtD
Pyrimethamine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0462	0.0592	CbGbCtD
Pyrimethamine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0442	0.0567	CbGbCtD
Pyrimethamine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0427	0.0547	CbGbCtD
Pyrimethamine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0423	0.0542	CbGbCtD
Pyrimethamine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0393	0.0504	CbGbCtD
Pyrimethamine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0348	0.0446	CbGbCtD
Pyrimethamine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0334	0.0428	CbGbCtD
Pyrimethamine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0334	0.0428	CbGbCtD
Pyrimethamine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0309	0.0395	CbGbCtD
Pyrimethamine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0306	0.0392	CbGbCtD
Pyrimethamine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0298	0.0382	CbGbCtD
Pyrimethamine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0282	0.0361	CbGbCtD
Pyrimethamine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0273	0.0349	CbGbCtD
Pyrimethamine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0253	0.0325	CbGbCtD
Pyrimethamine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0243	0.0311	CbGbCtD
Pyrimethamine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0232	0.0297	CbGbCtD
Pyrimethamine—CYP2C8—Losartan—type 2 diabetes mellitus	0.0224	0.0287	CbGbCtD
Pyrimethamine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0222	0.0285	CbGbCtD
Pyrimethamine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0171	0.0219	CbGbCtD
Pyrimethamine—CYP2C9—Losartan—type 2 diabetes mellitus	0.0157	0.0201	CbGbCtD
Pyrimethamine—Anaemia megaloblastic—Metformin—type 2 diabetes mellitus	0.00688	0.0549	CcSEcCtD
Pyrimethamine—Pulmonary eosinophilia—Ramipril—type 2 diabetes mellitus	0.00676	0.0539	CcSEcCtD
Pyrimethamine—Pancytopenia—Tolbutamide—type 2 diabetes mellitus	0.00277	0.0221	CcSEcCtD
Pyrimethamine—Pancytopenia—Tolazamide—type 2 diabetes mellitus	0.00252	0.0201	CcSEcCtD
Pyrimethamine—Pancytopenia—Chlorpropamide—type 2 diabetes mellitus	0.00252	0.0201	CcSEcCtD
Pyrimethamine—Erythema multiforme—Chlorpropamide—type 2 diabetes mellitus	0.00201	0.016	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Repaglinide—type 2 diabetes mellitus	0.00188	0.015	CcSEcCtD
Pyrimethamine—Erythema multiforme—Nateglinide—type 2 diabetes mellitus	0.00186	0.0148	CcSEcCtD
Pyrimethamine—Leukopenia—Tolbutamide—type 2 diabetes mellitus	0.00182	0.0145	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Rosiglitazone—type 2 diabetes mellitus	0.00178	0.0142	CcSEcCtD
Pyrimethamine—Pancytopenia—Glipizide—type 2 diabetes mellitus	0.00167	0.0133	CcSEcCtD
Pyrimethamine—Leukopenia—Chlorpropamide—type 2 diabetes mellitus	0.00165	0.0132	CcSEcCtD
Pyrimethamine—Leukopenia—Tolazamide—type 2 diabetes mellitus	0.00165	0.0132	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Tolbutamide—type 2 diabetes mellitus	0.00162	0.013	CcSEcCtD
Pyrimethamine—Erythema multiforme—Repaglinide—type 2 diabetes mellitus	0.00161	0.0128	CcSEcCtD
Pyrimethamine—Pancytopenia—Glimepiride—type 2 diabetes mellitus	0.00156	0.0124	CcSEcCtD
Pyrimethamine—Erythema multiforme—Rosiglitazone—type 2 diabetes mellitus	0.00152	0.0121	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.00149	0.0119	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Tolazamide—type 2 diabetes mellitus	0.00148	0.0118	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Chlorpropamide—type 2 diabetes mellitus	0.00148	0.0118	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Glimepiride—type 2 diabetes mellitus	0.00145	0.0116	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Sitagliptin—type 2 diabetes mellitus	0.00145	0.0115	CcSEcCtD
Pyrimethamine—Anorexia—Chlorpropamide—type 2 diabetes mellitus	0.00144	0.0115	CcSEcCtD
Pyrimethamine—Haematuria—Pioglitazone—type 2 diabetes mellitus	0.00143	0.0114	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Acarbose—type 2 diabetes mellitus	0.00142	0.0113	CcSEcCtD
Pyrimethamine—Leukopenia—Repaglinide—type 2 diabetes mellitus	0.00133	0.0106	CcSEcCtD
Pyrimethamine—Decreased appetite—Chlorpropamide—type 2 diabetes mellitus	0.00131	0.0105	CcSEcCtD
Pyrimethamine—Pancytopenia—Glyburide—type 2 diabetes mellitus	0.00128	0.0103	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Gliclazide—type 2 diabetes mellitus	0.00127	0.0101	CcSEcCtD
Pyrimethamine—Leukopenia—Rosiglitazone—type 2 diabetes mellitus	0.00125	0.01	CcSEcCtD
Pyrimethamine—Erythema multiforme—Glimepiride—type 2 diabetes mellitus	0.00124	0.00991	CcSEcCtD
Pyrimethamine—Erythema multiforme—Sitagliptin—type 2 diabetes mellitus	0.00124	0.00988	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00121	0.00965	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Repaglinide—type 2 diabetes mellitus	0.00118	0.00945	CcSEcCtD
Pyrimethamine—Pancytopenia—Gliclazide—type 2 diabetes mellitus	0.00115	0.00921	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00114	0.00912	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Rosiglitazone—type 2 diabetes mellitus	0.00112	0.00893	CcSEcCtD
Pyrimethamine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.0011	0.00877	CcSEcCtD
Pyrimethamine—Leukopenia—Glipizide—type 2 diabetes mellitus	0.0011	0.00876	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Gliclazide—type 2 diabetes mellitus	0.00107	0.00858	CcSEcCtD
Pyrimethamine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00107	0.00852	CcSEcCtD
Pyrimethamine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00103	0.00821	CcSEcCtD
Pyrimethamine—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.00102	0.00817	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Irbesartan—type 2 diabetes mellitus	0.000999	0.00798	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000979	0.00782	CcSEcCtD
Pyrimethamine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000958	0.00765	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.000958	0.00765	CcSEcCtD
Pyrimethamine—Anorexia—Glipizide—type 2 diabetes mellitus	0.000953	0.00761	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Losartan—type 2 diabetes mellitus	0.000941	0.00751	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000933	0.00745	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00093	0.00743	CcSEcCtD
Pyrimethamine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000921	0.00735	CcSEcCtD
Pyrimethamine—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.000919	0.00734	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000913	0.00729	CcSEcCtD
Pyrimethamine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00089	0.00711	CcSEcCtD
Pyrimethamine—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000889	0.0071	CcSEcCtD
Pyrimethamine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000888	0.00709	CcSEcCtD
Pyrimethamine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000869	0.00694	CcSEcCtD
Pyrimethamine—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000844	0.00674	CcSEcCtD
Pyrimethamine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000811	0.00648	CcSEcCtD
Pyrimethamine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000808	0.00646	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000806	0.00644	CcSEcCtD
Pyrimethamine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000802	0.00641	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000798	0.00637	CcSEcCtD
Pyrimethamine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000768	0.00614	CcSEcCtD
Pyrimethamine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000758	0.00605	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000753	0.00602	CcSEcCtD
Pyrimethamine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000737	0.00588	CcSEcCtD
Pyrimethamine—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000735	0.00587	CcSEcCtD
Pyrimethamine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000733	0.00586	CcSEcCtD
Pyrimethamine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000732	0.00584	CcSEcCtD
Pyrimethamine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000706	0.00563	CcSEcCtD
Pyrimethamine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000687	0.00549	CcSEcCtD
Pyrimethamine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000685	0.00547	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000684	0.00546	CcSEcCtD
Pyrimethamine—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000683	0.00546	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000676	0.0054	CcSEcCtD
Pyrimethamine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000669	0.00534	CcSEcCtD
Pyrimethamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000636	0.00508	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000635	0.00507	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000627	0.00501	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000621	0.00496	CcSEcCtD
Pyrimethamine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000605	0.00483	CcSEcCtD
Pyrimethamine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000598	0.00478	CcSEcCtD
Pyrimethamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000593	0.00474	CcSEcCtD
Pyrimethamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000591	0.00472	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000586	0.00468	CcSEcCtD
Pyrimethamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000567	0.00453	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000566	0.00452	CcSEcCtD
Pyrimethamine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000563	0.0045	CcSEcCtD
Pyrimethamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000552	0.00441	CcSEcCtD
Pyrimethamine—Anorexia—Metformin—type 2 diabetes mellitus	0.000551	0.0044	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000545	0.00436	CcSEcCtD
Pyrimethamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000545	0.00435	CcSEcCtD
Pyrimethamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000535	0.00427	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000534	0.00426	CcSEcCtD
Pyrimethamine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00052	0.00415	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000513	0.0041	CcSEcCtD
Pyrimethamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000509	0.00406	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000503	0.00401	CcSEcCtD
Pyrimethamine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000502	0.00401	CcSEcCtD
Pyrimethamine—Anorexia—Losartan—type 2 diabetes mellitus	0.000489	0.00391	CcSEcCtD
Pyrimethamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000489	0.00391	CcSEcCtD
Pyrimethamine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000483	0.00386	CcSEcCtD
Pyrimethamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000474	0.00379	CcSEcCtD
Pyrimethamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000468	0.00373	CcSEcCtD
Pyrimethamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000462	0.00369	CcSEcCtD
Pyrimethamine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000446	0.00356	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00044	0.00352	CcSEcCtD
Pyrimethamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000439	0.00351	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000431	0.00344	CcSEcCtD
Pyrimethamine—Anorexia—Ramipril—type 2 diabetes mellitus	0.00042	0.00335	CcSEcCtD
Pyrimethamine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000404	0.00322	CcSEcCtD
Pyrimethamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000402	0.00321	CcSEcCtD
Pyrimethamine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000399	0.00318	CcSEcCtD
Pyrimethamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000383	0.00306	CcSEcCtD
Pyrimethamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000378	0.00302	CcSEcCtD
Pyrimethamine—Vomiting—Metformin—type 2 diabetes mellitus	0.000368	0.00293	CcSEcCtD
Pyrimethamine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000347	0.00277	CcSEcCtD
Pyrimethamine—Vomiting—Losartan—type 2 diabetes mellitus	0.000326	0.00261	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000324	0.00259	CcSEcCtD
Pyrimethamine—Vomiting—Ramipril—type 2 diabetes mellitus	0.00028	0.00223	CcSEcCtD
Pyrimethamine—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	2.61e-05	0.000277	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.59e-05	0.000275	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCC8—type 2 diabetes mellitus	2.59e-05	0.000275	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CBS—type 2 diabetes mellitus	2.59e-05	0.000275	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.58e-05	0.000274	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.58e-05	0.000274	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.58e-05	0.000274	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.58e-05	0.000274	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.58e-05	0.000274	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	2.52e-05	0.000268	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SERPINE1—type 2 diabetes mellitus	2.52e-05	0.000268	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.5e-05	0.000266	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC5A2—type 2 diabetes mellitus	2.49e-05	0.000265	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—COX2—type 2 diabetes mellitus	2.49e-05	0.000265	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NCOA6—type 2 diabetes mellitus	2.45e-05	0.00026	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.44e-05	0.00026	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.41e-05	0.000256	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3R1—type 2 diabetes mellitus	2.41e-05	0.000256	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—NOS3—type 2 diabetes mellitus	2.41e-05	0.000256	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—UCP3—type 2 diabetes mellitus	2.4e-05	0.000255	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—UCP2—type 2 diabetes mellitus	2.4e-05	0.000255	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HSD11B1—type 2 diabetes mellitus	2.4e-05	0.000255	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	2.38e-05	0.000253	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	2.38e-05	0.000253	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	2.36e-05	0.000251	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	2.36e-05	0.000251	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PPARG—type 2 diabetes mellitus	2.34e-05	0.000249	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.33e-05	0.000248	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	2.32e-05	0.000247	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	2.3e-05	0.000245	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—INS—type 2 diabetes mellitus	2.3e-05	0.000244	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PCK1—type 2 diabetes mellitus	2.26e-05	0.00024	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.23e-05	0.000236	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	2.21e-05	0.000235	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	2.21e-05	0.000235	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	2.21e-05	0.000235	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—type 2 diabetes mellitus	2.2e-05	0.000234	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	2.2e-05	0.000233	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	2.2e-05	0.000233	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	2.2e-05	0.000233	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.17e-05	0.000231	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	2.12e-05	0.000226	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	2.12e-05	0.000226	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HK1—type 2 diabetes mellitus	2.12e-05	0.000225	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.11e-05	0.000225	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALB—type 2 diabetes mellitus	2.11e-05	0.000224	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	2.11e-05	0.000224	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	2.11e-05	0.000224	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LPA—type 2 diabetes mellitus	2.04e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GCKR—type 2 diabetes mellitus	2.04e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—KCNJ11—type 2 diabetes mellitus	2.04e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HSD3B2—type 2 diabetes mellitus	2.04e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	2.04e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	2.04e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	2.03e-05	0.000215	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	2.03e-05	0.000215	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3R1—type 2 diabetes mellitus	2.01e-05	0.000214	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NOS3—type 2 diabetes mellitus	2.01e-05	0.000214	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	2.01e-05	0.000213	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.99e-05	0.000212	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.99e-05	0.000211	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.97e-05	0.00021	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.97e-05	0.00021	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.97e-05	0.00021	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.97e-05	0.000209	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	1.96e-05	0.000208	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.96e-05	0.000208	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.96e-05	0.000208	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.96e-05	0.000208	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.9e-05	0.000202	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.9e-05	0.000202	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.87e-05	0.000198	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.86e-05	0.000197	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.84e-05	0.000196	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—type 2 diabetes mellitus	1.84e-05	0.000196	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.84e-05	0.000196	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	1.82e-05	0.000194	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.81e-05	0.000192	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SRC—type 2 diabetes mellitus	1.78e-05	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.77e-05	0.000188	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.74e-05	0.000185	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.72e-05	0.000183	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.72e-05	0.000183	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	1.7e-05	0.000181	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.68e-05	0.000178	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.68e-05	0.000178	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.68e-05	0.000178	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.68e-05	0.000178	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	1.67e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	1.67e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.66e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.66e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.66e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.66e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	1.63e-05	0.000174	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.63e-05	0.000173	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	1.62e-05	0.000173	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	1.62e-05	0.000173	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	1.62e-05	0.000173	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	1.61e-05	0.000172	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.61e-05	0.000171	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.6e-05	0.00017	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.6e-05	0.00017	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—type 2 diabetes mellitus	1.59e-05	0.000169	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	1.59e-05	0.000168	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	1.57e-05	0.000167	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—EGFR—type 2 diabetes mellitus	1.56e-05	0.000166	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.55e-05	0.000165	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.52e-05	0.000161	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.5e-05	0.000159	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.5e-05	0.000159	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.48e-05	0.000158	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.46e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	1.46e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	1.46e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	1.46e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	1.43e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	1.42e-05	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.4e-05	0.000149	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.4e-05	0.000148	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	1.39e-05	0.000147	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.38e-05	0.000147	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.37e-05	0.000145	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.37e-05	0.000145	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.36e-05	0.000144	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.36e-05	0.000144	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.34e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.33e-05	0.000142	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.33e-05	0.000142	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.33e-05	0.000142	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	1.33e-05	0.000142	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.33e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.33e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.32e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.32e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.32e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.32e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	1.32e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	1.32e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.31e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.3e-05	0.000138	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.29e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.29e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	1.28e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.28e-05	0.000136	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.28e-05	0.000136	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.26e-05	0.000134	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.26e-05	0.000134	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—type 2 diabetes mellitus	1.2e-05	0.000127	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.2e-05	0.000127	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.2e-05	0.000127	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.2e-05	0.000127	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.19e-05	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.19e-05	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.19e-05	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.19e-05	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.17e-05	0.000125	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.16e-05	0.000124	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.16e-05	0.000124	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.15e-05	0.000123	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.14e-05	0.000121	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.14e-05	0.000121	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.13e-05	0.00012	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—type 2 diabetes mellitus	1.11e-05	0.000117	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.09e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.09e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.09e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.07e-05	0.000114	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.07e-05	0.000114	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.07e-05	0.000114	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.05e-05	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.05e-05	0.000111	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.04e-05	0.000111	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.04e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.04e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.04e-05	0.00011	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.03e-05	0.000109	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.03e-05	0.000109	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.01e-05	0.000107	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	9.91e-06	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	9.7e-06	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	9.67e-06	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	9.42e-06	0.0001	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	9.3e-06	9.88e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—type 2 diabetes mellitus	9.26e-06	9.84e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.94e-06	9.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	8.94e-06	9.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	8.93e-06	9.48e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	8.9e-06	9.45e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.86e-06	9.41e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	8.86e-06	9.41e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	8.82e-06	9.37e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	8.78e-06	9.33e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	8.76e-06	9.3e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	8.7e-06	9.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	8.52e-06	9.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	8.48e-06	9.01e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	8.45e-06	8.98e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	8.34e-06	8.86e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	8.31e-06	8.83e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	8.29e-06	8.81e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	8.22e-06	8.73e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	8.21e-06	8.73e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	8.14e-06	8.65e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	8.07e-06	8.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	7.97e-06	8.46e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	7.94e-06	8.44e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	7.9e-06	8.39e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	7.87e-06	8.36e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	7.73e-06	8.21e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.67e-06	8.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.64e-06	8.11e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	7.57e-06	8.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	7.33e-06	7.78e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	7.26e-06	7.72e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	7.24e-06	7.69e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	7.19e-06	7.64e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	7.13e-06	7.57e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	7.1e-06	7.54e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	6.96e-06	7.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.9e-06	7.33e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	6.85e-06	7.27e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	6.82e-06	7.25e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.79e-06	7.21e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.76e-06	7.18e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.74e-06	7.16e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.68e-06	7.1e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	6.51e-06	6.91e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	6.22e-06	6.61e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	6.22e-06	6.61e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.94e-06	6.31e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.89e-06	6.26e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.83e-06	6.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.78e-06	6.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	5.69e-06	6.05e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.34e-06	5.68e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.3e-06	5.63e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.11e-06	5.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.11e-06	5.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.07e-06	5.38e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	5.07e-06	5.38e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.67e-06	4.97e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.63e-06	4.92e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.86e-06	3.04e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.35e-06	2.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.33e-06	2.47e-05	CbGpPWpGaD
